ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.20
0.00 (0.00%)
Jul 8, 2026, 9:21 AM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 94.68 million as of July 8, 2026. Its market cap has increased by 74.87% in one year.
Market Cap
94.68M
Enterprise Value
76.62M
Revenue
9.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.20
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 94.68M, a decrease of -63.48%. That is a compound annual growth rate of -11.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 94.68M | -24.16% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.43T |
| Genmab | 116.43B |
| Coloplast | 91.53B |
| Demant | 58.17B |
| Gubra | 5.66B |
| BioPorto | 544.62M |
| Pharma Equity Group | 97.22M |
| Scandinavian Medical Solutions | 82.58M |